• contact
  • |
  • site map
  • |
  • careers
 
  • Home
  • About Us
    • Overview
    • Executive Team
    • Board of Directors
    • Collaborations
    • Mission
    • Corporate History
    • Advisors
  • Technology
    • Overview
    • Innovation @ Chikujee
    • Focused Diversification
    • Drug Development
    • Advantages
    • Personalized Healthcare
    • Clinical Trials
  • Products
    • Overview
    • Autism
    • Targeted Therapeutics
    • Biomarker Monitoring
    • Personalized Products
  • Investors
    • Overview
    • Investment Highlights
    • IP Strategy
    • Business Strategy
    • Investor Contacts
  • News & Events
    • News
    • Events
    • Corporate Fact Sheet
    • Corporate Library
    • Media Contacts
    • Join Mailing List
  • Careers
    • Overview
    • Culture
    • Diversity
    • Job Opportunities

Home › Overview › Clinical Monitoring of Cancer Biomarkers
  • Overview
  • Personalized Product Portfolio
  • Diagnostics
  • Targeted Therapeutics
  • Clinical Monitoring
  • Personalized Healthcare
  • Clinical Pipeline



 

Clinical Monitoring Products

 

Overview

 

 

At Chikujee Therapeutics, we are developing an entirely new class of personalized medicines that provide a cancer cell-specific detection and/or a tumor marker-specific targeted therapeutic and cancer monitoring capabilities to healthcare professional. The diagnostics, therapeutic and monitoring capabilities are non-invasive and extremely patient-friendly.

Clinical Biomarkers is key step on the path to the promise of personalized medicine.

Clinical monitoring of cancer biomarkers: Using an approach that is similar to detection, the same cancer biomarkers can be monitored by monitoring the intensity of the nanoparticles within the tumors by non-invasive methods like MRI. Examples of applications include monitoring of ER specific nanobindi probe to monitor the clinical efficacy of treatment by MRI. 

 

 

 

 

 

 

© 2012 Chikujee Therapeutics | Privacy Policy | Terms of Use | Join Mailing List